129 related articles for article (PubMed ID: 36306724)
1. CHD4 plays a critical role in arsenite-induced oxidative damage in human urothelial carcinoma.
Chang SJ; Bin PJ; Luo CW; Chai CY
Pathol Res Pract; 2022 Dec; 240():154173. PubMed ID: 36306724
[TBL] [Abstract][Full Text] [Related]
2. CHD4 Has Oncogenic Functions in Initiating and Maintaining Epigenetic Suppression of Multiple Tumor Suppressor Genes.
Xia L; Huang W; Bellani M; Seidman MM; Wu K; Fan D; Nie Y; Cai Y; Zhang YW; Yu LR; Li H; Zahnow CA; Xie W; Chiu Yen RW; Rassool FV; Baylin SB
Cancer Cell; 2017 May; 31(5):653-668.e7. PubMed ID: 28486105
[TBL] [Abstract][Full Text] [Related]
3. Aldehyde dehydrogenase induction in arsenic-exposed rat bladder epithelium.
Huang YC; Yu HS; Chai CY
Exp Toxicol Pathol; 2016 Jan; 68(1):61-8. PubMed ID: 26482281
[TBL] [Abstract][Full Text] [Related]
4. Effects of DNMT and MEK inhibitors on the expression of RECK, MMP-9, -2, uPA and VEGF in response to arsenite stimulation in human uroepithelial cells.
Huang YC; Hung WC; Chen WT; Yu HS; Chai CY
Toxicol Lett; 2011 Feb; 201(1):62-71. PubMed ID: 21167264
[TBL] [Abstract][Full Text] [Related]
5. Sodium arsenite-induced abnormalities in expressions of Caveolin-1, eNOS, IKKβ, and COX-2 in SV-40 immortalized human uroepithelial cells and in urothelial carcinomas.
Liu XP; Huang YC; Hung WC; Chen WT; Yu HS; Chai CY
Toxicol In Vitro; 2012 Oct; 26(7):1098-105. PubMed ID: 22824620
[TBL] [Abstract][Full Text] [Related]
6. Chromodomain helicase DNA-binding protein 4 (CHD4) regulates homologous recombination DNA repair, and its deficiency sensitizes cells to poly(ADP-ribose) polymerase (PARP) inhibitor treatment.
Pan MR; Hsieh HJ; Dai H; Hung WC; Li K; Peng G; Lin SY
J Biol Chem; 2012 Feb; 287(9):6764-72. PubMed ID: 22219182
[TBL] [Abstract][Full Text] [Related]
7. Expression of WWOX and FHIT is downregulated by exposure to arsenite in human uroepithelial cells.
Huang YC; Hung WC; Chen WT; Yu HS; Chai CY
Toxicol Lett; 2013 Jul; 220(2):118-25. PubMed ID: 23618899
[TBL] [Abstract][Full Text] [Related]
8. Urinary 8-hydroxydeoxyguanosine and urothelial carcinoma risk in low arsenic exposure area.
Chung CJ; Huang CJ; Pu YS; Su CT; Huang YK; Chen YT; Hsueh YM
Toxicol Appl Pharmacol; 2008 Jan; 226(1):14-21. PubMed ID: 17950770
[TBL] [Abstract][Full Text] [Related]
9. Acetyltransferase p300 collaborates with chromodomain helicase DNA-binding protein 4 (CHD4) to facilitate DNA double-strand break repair.
Qi W; Chen H; Xiao T; Wang R; Li T; Han L; Zeng X
Mutagenesis; 2016 Mar; 31(2):193-203. PubMed ID: 26546801
[TBL] [Abstract][Full Text] [Related]
10. MiADMSA ameliorate arsenic induced urinary bladder carcinogenesis in vivo and in vitro.
Sathua K; Srivastava S; Flora SJS
Biomed Pharmacother; 2020 Aug; 128():110257. PubMed ID: 32474354
[TBL] [Abstract][Full Text] [Related]
11. The N-terminal Region of Chromodomain Helicase DNA-binding Protein 4 (CHD4) Is Essential for Activity and Contains a High Mobility Group (HMG) Box-like-domain That Can Bind Poly(ADP-ribose).
Silva AP; Ryan DP; Galanty Y; Low JK; Vandevenne M; Jackson SP; Mackay JP
J Biol Chem; 2016 Jan; 291(2):924-38. PubMed ID: 26565020
[TBL] [Abstract][Full Text] [Related]
12. Aberrant β-catenin expression in urothelial carcinomas in blackfoot disease-endemic areas.
Chen YT; Wu CC; Liu XP; Chai CY
Kaohsiung J Med Sci; 2017 Jan; 33(1):11-16. PubMed ID: 28088268
[TBL] [Abstract][Full Text] [Related]
13. SIRT6 coordinates with CHD4 to promote chromatin relaxation and DNA repair.
Hou T; Cao Z; Zhang J; Tang M; Tian Y; Li Y; Lu X; Chen Y; Wang H; Wei FZ; Wang L; Yang Y; Zhao Y; Wang Z; Wang H; Zhu WG
Nucleic Acids Res; 2020 Apr; 48(6):2982-3000. PubMed ID: 31970415
[TBL] [Abstract][Full Text] [Related]
14. Defeating EpCAM(+) liver cancer stem cells by targeting chromatin remodeling enzyme CHD4 in human hepatocellular carcinoma.
Nio K; Yamashita T; Okada H; Kondo M; Hayashi T; Hara Y; Nomura Y; Zeng SS; Yoshida M; Hayashi T; Sunagozaka H; Oishi N; Honda M; Kaneko S
J Hepatol; 2015 Nov; 63(5):1164-72. PubMed ID: 26095183
[TBL] [Abstract][Full Text] [Related]
15. CHD4 mediates proliferation and migration of non-small cell lung cancer via the RhoA/ROCK pathway by regulating PHF5A.
Xu N; Liu F; Wu S; Ye M; Ge H; Zhang M; Song Y; Tong L; Zhou J; Bai C
BMC Cancer; 2020 Mar; 20(1):262. PubMed ID: 32228507
[TBL] [Abstract][Full Text] [Related]
16. CHD4 in the DNA-damage response and cell cycle progression: not so NuRDy now.
O'Shaughnessy A; Hendrich B
Biochem Soc Trans; 2013 Jun; 41(3):777-82. PubMed ID: 23697937
[TBL] [Abstract][Full Text] [Related]
17. Effects of MEK and DNMT inhibitors on arsenic-treated human uroepithelial cells in relation to Cyclin-D1 and p16.
Huang YC; Hung WC; Chen WT; Jiang WH; Yu HS; Chai CY
Toxicol Lett; 2011 Jan; 200(1-2):59-66. PubMed ID: 21040761
[TBL] [Abstract][Full Text] [Related]
18. The chromatin-remodeling factor CHD4 coordinates signaling and repair after DNA damage.
Larsen DH; Poinsignon C; Gudjonsson T; Dinant C; Payne MR; Hari FJ; Rendtlew Danielsen JM; Menard P; Sand JC; Stucki M; Lukas C; Bartek J; Andersen JS; Lukas J
J Cell Biol; 2010 Sep; 190(5):731-40. PubMed ID: 20805324
[TBL] [Abstract][Full Text] [Related]
19. Chromodomain helicase DNA-binding 4 (CHD4) regulates early B cell identity and V(D)J recombination.
Hagman JR; Arends T; Laborda C; Knapp JR; Harmacek L; O'Connor BP
Immunol Rev; 2022 Jan; 305(1):29-42. PubMed ID: 34927255
[TBL] [Abstract][Full Text] [Related]
20. CHD4 orchestrates the symphony of T and B lymphocytes development and a good mediator in preventing from autoimmune disease.
Jia M; Zou X; Yin S; Tian W; Zhao Y; Wang H; Xu G; Cai W; Shao Q
Immun Inflamm Dis; 2022 Jul; 10(7):e644. PubMed ID: 35759243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
